Article History
Accepted: 19 April 2023
First Online: 24 May 2023
Compliance with Ethical Standards
:
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: Paschalis Vergidis has received research funding from Cidara, Scynexis and Ansun, and has served on the DSMB for AbbVie (all fees have been paid to Mayo Clinic). Ryan Stevens has no conflict of interest. Samir Agrawal has received funding from Gilead, meeting support from Hikma, and honoraria from Shionogi and NAPP/Mundipharma. He has served on the advisory board for Pfizer.